• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Orthofix Medical Inc.

    4/29/26 4:27:10 PM ET
    $OFIX
    Medical/Dental Instruments
    Health Care
    Get the next $OFIX alert in real time by email
    DEFA14A 1 ofix_2026_def_a_14a.htm DEFA14A DEFA14A

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    SCHEDULE 14A INFORMATION

    Proxy Statement Pursuant to Section 14(a) of the Securities

    Exchange Act of 1934 (Amendment No. )

    Filed by the Registrant  Filed by a Party other than the Registrant 

    Check the appropriate box:

     

    

     

    Preliminary Proxy Statement

     

     

    

     

    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

     

     

    

     

    Definitive Proxy Statement

     

     

    

     

    Definitive Additional Materials

     

     

    

     

    Soliciting Material Pursuant to §240.14a-12

    img24736290_0.jpg

    ORTHOFIX MEDICAL INC.

    (Name of Registrant as Specified In Its Charter)

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    Payment of Filing Fee (Check the appropriate box):

     

    

     

    No fee required.

     

     

    ☐

     

    Fee paid previously with preliminary materials

     

     

    

     

    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

     

     


    img24736290_1.jpgP.O. BOX 8016, CARY, NC 27512-9903 Your vote matters! Orthofix Medical Inc. Annual Meeting of Shareholders Wednesday, June 10, 2026 at 8:00 AM Central Daylight Time Renaissance Dallas at Plano Legacy West, 6007 Legacy Drive, Plano, TX 75024 Meeting Materials: Notice of Meeting and Proxy Statement & Annual Report on Form 10-K Important Notice Regarding the Availability of Proxy Materials for the Shareholders Meeting to Be Held on June 10, 2026 for Shareholders of Record as of April 13, 2026 To request a copy of the proxy materials, use one of the following methods. For a convenient way to view proxy materials, VOTE, and obtain directions to attend the meeting, go to www.proxydocs.com/OFIX. To vote your proxy while visiting this site, you will need the 12 digit control number in the box below. This communication presents only an overview of the more complete proxy materials that are available to you on the internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting. Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper form. Proxy materials can be distributed by making them available on the internet. If you want to receive a paper or e-mail copy of the materials relating to this meeting and future shareholder meetings, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year's meeting, you must make this request on or before May 29, 2026. Unless requested by this date, you will not otherwise receive a paper or email copy of the proxy materials. SEE REVERSE FOR FULL AGENDA Internet: www.investorelections.com/OFIX Call: 1-866-648-8133 Email: paper@investorelections.com * If requesting proxy materials by e-mail, please send a blank e-mail with the 12 digit control number (located below) in the subject line. No other requests, instructions OR other inquiries should be included with your email requesting proxy materials. Your control number Have the 12 digit control number located in the box above available when you access the website and follow the instructions. Copyright 2026 BetaNXT, Inc. or its affiliates. All Rights Reserved

     


     

    img24736290_2.jpg Orthofix Medical Inc. Annual Meeting of Shareholders THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE: FOR all the listed director nominees and FOR PROPOSALS 2, 3 AND 4 PROPOSAL 1. Election of Directors 1.01 Alan L. Bazaar 1.02 Wayne Burris 1.03 Massimo Calafiore 1.04 Vickie L. Capps 1.05 Michael M. Finegan 1.06 Jason M. Hannon 1.07 John B. Henneman, III 1.08 Charles R. Kummeth 1.09 Shweta S. Maniar 1.10 Michael E. Paolucci 2. Advisory and Non-Binding Vote to Approve Executive Compensation. 3. Ratification of the Appointment of Ernst & Young LLP as Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026. 4. Approval of Amendment No. 5 to the Second Amended and Restated Stock Purchase Plan.

     


    Get the next $OFIX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OFIX

    DatePrice TargetRatingAnalyst
    1/27/2026$14.00Hold
    TD Cowen
    10/28/2025$22.00Buy
    Stifel
    1/22/2025$24.00Buy
    Canaccord Genuity
    11/8/2024$18.00 → $24.00Hold → Buy
    Stifel
    5/8/2024$15.00 → $20.00Neutral → Buy
    ROTH MKM
    10/20/2023$12.00Neutral
    ROTH MKM
    9/12/2023Buy → Neutral
    BTIG Research
    9/12/2023Buy → Hold
    Stifel
    More analyst ratings

    $OFIX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Henneman John B Iii bought $61,295 worth of shares (5,000 units at $12.26), increasing direct ownership by 6% to 90,809 units (SEC Form 4)

    4 - Orthofix Medical Inc. (0000884624) (Issuer)

    5/8/26 4:52:20 PM ET
    $OFIX
    Medical/Dental Instruments
    Health Care

    Large owner Engine Capital Management, Lp bought $2,232,927 worth of shares (184,896 units at $12.08) (SEC Form 4)

    4 - Orthofix Medical Inc. (0000884624) (Issuer)

    5/7/26 6:15:58 PM ET
    $OFIX
    Medical/Dental Instruments
    Health Care

    Director Capps Vickie L bought $62,324 worth of shares (5,000 units at $12.46), increasing direct ownership by 22% to 27,585 units (SEC Form 4)

    4 - Orthofix Medical Inc. (0000884624) (Issuer)

    3/10/26 4:13:55 PM ET
    $OFIX
    Medical/Dental Instruments
    Health Care

    $OFIX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Large owner Juniper Investment Company, Llc

    4 - Orthofix Medical Inc. (0000884624) (Issuer)

    5/29/26 4:57:32 PM ET
    $OFIX
    Medical/Dental Instruments
    Health Care

    New insider Juniper Investment Company, Llc claimed ownership of 4,200,543 shares (SEC Form 3)

    3 - Orthofix Medical Inc. (0000884624) (Issuer)

    5/29/26 2:59:08 PM ET
    $OFIX
    Medical/Dental Instruments
    Health Care

    Director Henneman John B Iii bought $61,295 worth of shares (5,000 units at $12.26), increasing direct ownership by 6% to 90,809 units (SEC Form 4)

    4 - Orthofix Medical Inc. (0000884624) (Issuer)

    5/8/26 4:52:20 PM ET
    $OFIX
    Medical/Dental Instruments
    Health Care

    $OFIX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Orthofix to Participate in Upcoming Investor Conferences

    Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that Orthofix will participate in the following investor conferences: Goldman Sachs 47th Annual Global Healthcare Conference - Miami Beach, June 8, 2026, Fireside Chat Time: 8:40 am Eastern Time Truist Securities MedTech Conference - Boston, June 16, 2026, 1x1 Meetings Only Interested parties can access the live and archived webcast of the Goldman Sachs fireside chat in the "Events & Presentations" section of the Orthofix Investor Relations Website at ir.orthofix.com. Internet Posting of Information Orthofix regularly shares important updates in the "Investors" section of its websi

    5/18/26 7:00:00 AM ET
    $OFIX
    Medical/Dental Instruments
    Health Care

    Orthofix Expands Pediatric Limb Reconstruction Portfolio with New FITBONE™ Innovation at POSNA 2026 Annual Meeting

    Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced new pediatric limb reconstruction innovations that expand treatment options for pediatric and small stature patients. The Company will highlight these advances at the Pediatric Orthopedic Society of North America (POSNA) 2026 Annual Meeting, which takes place May 6-8, 2026, at the Rosen Shingle Creek Hotel in Orlando, Florida. At POSNA 2026, Orthofix will showcase its comprehensive pediatric limb reconstruction portfolio at exhibit booth #34, including the recently launched FITBONE Trochanteric Intramedullary Lengthening System and new enhancements to its OrthoNext™ planning software platform

    5/6/26 7:00:00 AM ET
    $OFIX
    Medical/Dental Instruments
    Health Care

    Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance

      Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the first quarter ended March 31, 2026, reflecting steady execution following recent spine commercial channel actions. Based on first-quarter performance, the Company reaffirmed its full-year 2026 financial guidance. All pro forma measures contained within this release exclude the impact of the Company's decision to discontinue its M6™ product lines. Highlights First quarter 2026 reported net sales of $196.7 million, including sales from M6 artificial cervical and lumbar discs. Non-GAAP pro forma net sales of $196.4 million, excluding sales from M6 discs, incre

    5/5/26 7:00:00 AM ET
    $OFIX
    Medical/Dental Instruments
    Health Care

    $OFIX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen initiated coverage on Orthofix with a new price target

    TD Cowen initiated coverage of Orthofix with a rating of Hold and set a new price target of $14.00

    1/27/26 8:48:16 AM ET
    $OFIX
    Medical/Dental Instruments
    Health Care

    Stifel resumed coverage on Orthofix with a new price target

    Stifel resumed coverage of Orthofix with a rating of Buy and set a new price target of $22.00

    10/28/25 7:09:19 AM ET
    $OFIX
    Medical/Dental Instruments
    Health Care

    Canaccord Genuity initiated coverage on Orthofix with a new price target

    Canaccord Genuity initiated coverage of Orthofix with a rating of Buy and set a new price target of $24.00

    1/22/25 7:47:50 AM ET
    $OFIX
    Medical/Dental Instruments
    Health Care

    $OFIX
    SEC Filings

    View All

    SEC Form SD filed by Orthofix Medical Inc.

    SD - Orthofix Medical Inc. (0000884624) (Filer)

    5/29/26 10:13:47 AM ET
    $OFIX
    Medical/Dental Instruments
    Health Care

    Orthofix Medical Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Orthofix Medical Inc. (0000884624) (Filer)

    5/21/26 8:00:44 AM ET
    $OFIX
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by Orthofix Medical Inc.

    10-Q - Orthofix Medical Inc. (0000884624) (Filer)

    5/5/26 7:03:46 AM ET
    $OFIX
    Medical/Dental Instruments
    Health Care

    $OFIX
    Leadership Updates

    Live Leadership Updates

    View All

    Fox Factory Announces Strategic Board Refresh

    Company to Appoint Two New Independent Directors and Form Transformation Committee Focused on Operational Excellence and Margin Improvement Company Enters into Cooperation Agreement with Engine Capital DULUTH, Ga., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Fox Factory Holding Corp. (Nasdaq: FOXF) ("Fox Factory" or the "Company"), a premium brand and a global leader in the design, engineering and manufacturing of performance-defining products and systems for customers worldwide, today announced that following constructive discussions with Engine Capital ("Engine Capital") regarding opportunities to enhance operational performance and profitability, the Company will be undertaking a strategic boar

    2/9/26 4:05:00 PM ET
    $FOXF
    $OFIX
    Motor Vehicles
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care

    Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

    Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the appointment of Maria Sainz to its Board of Directors effective as of January 9, 2026. "We are delighted to welcome Maria to our Board of Directors," said Pulse Biosciences' Co-Chairman of the Board Robert W. Duggan. "She brings an exceptionally strong track record of guiding both public and private medical device companies through growth, commercialization, viability, and scale. Her strategic and operational expertise will be invaluable as Pulse begins creating and disrupting interventional m

    1/9/26 7:00:00 AM ET
    $AVNS
    $HYPR
    $OFIX
    Industrial Specialties
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Medical/Dental Instruments

    Orthofix Announces Appointment of Vickie Capps to Board of Directors

    Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced the appointment of Vickie Capps to the Company's Board of Directors, effective March 11, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250312538957/en/Vickie Capps (Photo: Business Wire) "Vickie brings a wealth of experience to our Board at a pivotal stage for Orthofix," said Michael Finegan, Chairman of Orthofix. "Her expertise in global business operations, strategic business development and corporate finance will provide the Board with a tremendously valuable perspective as we seek to deliver profitable growth and significa

    3/12/25 8:00:00 AM ET
    $OFIX
    Medical/Dental Instruments
    Health Care

    $OFIX
    Financials

    Live finance-specific insights

    View All

    Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance

      Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the first quarter ended March 31, 2026, reflecting steady execution following recent spine commercial channel actions. Based on first-quarter performance, the Company reaffirmed its full-year 2026 financial guidance. All pro forma measures contained within this release exclude the impact of the Company's decision to discontinue its M6™ product lines. Highlights First quarter 2026 reported net sales of $196.7 million, including sales from M6 artificial cervical and lumbar discs. Non-GAAP pro forma net sales of $196.4 million, excluding sales from M6 discs, incre

    5/5/26 7:00:00 AM ET
    $OFIX
    Medical/Dental Instruments
    Health Care

    Orthofix to Report First Quarter 2026 Financial Results

    Company to Host Conference Call on Tuesday, May 5, 2026, at 8:30 am Eastern Time Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referencing the conference ID 7578740. A webcast of the conference call and a copy of the release may be accessed at ir.Orthofix.com. Internet Posting of Informati

    4/21/26 7:00:00 AM ET
    $OFIX
    Medical/Dental Instruments
    Health Care

    Orthofix Realigns Spine Leadership to Strengthen Focus and Execution

    Company Reports Preliminary First Quarter 2026 Net Sales and Reaffirms 2026 Outlook Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced a strategic realignment of its Spine leadership team designed to accelerate profitable growth and sharpen execution across its commercial and innovation priorities. The Company also reported preliminary, unaudited net sales results for the first quarter ended March 31, 2026. Spine Leadership Realignment To accelerate decision-making, sharpen leadership accountability, and further advance commercialization of the 7D™ navigation platform, Orthofix has streamlined its Spine organization by eliminating the rol

    4/9/26 7:00:00 AM ET
    $OFIX
    Medical/Dental Instruments
    Health Care

    $OFIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Orthofix Medical Inc.

    SC 13G/A - Orthofix Medical Inc. (0000884624) (Subject)

    11/14/24 5:20:27 PM ET
    $OFIX
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Orthofix Medical Inc.

    SC 13G - Orthofix Medical Inc. (0000884624) (Subject)

    11/13/24 5:03:21 PM ET
    $OFIX
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D/A filed by Orthofix Medical Inc. (Amendment)

    SC 13D/A - Orthofix Medical Inc. (0000884624) (Subject)

    4/22/24 5:00:33 PM ET
    $OFIX
    Medical/Dental Instruments
    Health Care